NCT02433483: Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients |
|
|
| Terminated | 2 | 4 | US | Cytarabine, Cytosine arabinoside, Ara-C, Cytosar®, Intrathecal Triples, ITMHA, Methotrexate/hydrocortisone/cytarabine, HPC-A, Donor infusion, Hematopoietic Progenitor Cell, Apheresis | St. Jude Children's Research Hospital, Cookies for Kids' Cancer | Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | 05/17 | 05/17 | | |
NCT00626626: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation |
|
|
| Terminated | 1/2 | 8 | US | Clofar, Cyclophos, Alemtuzumab, CLOLAR, Clofar, Cyclophos,Alemtuzumab(Ph II), Clolar, Campath | Milton S. Hershey Medical Center | Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma | 01/10 | 01/10 | | |
